PCSA vs PFG · $5.9M cap vs P/E 16, rev $15.63B
Processa Pharmaceuticals Inc (PCSA) versus Principal Financial Group Inc (PFG) — a side-by-side from cached financials, not a winner call.
Processa Pharmaceuticals Inc (PCSA) is a biotechnology company listed on NASDAQ.
Principal Financial Group Inc (PFG) is a asset management company listed on NASDAQ.
PCSA does not have a complete income-statement cache yet.
Latest reported PFG revenue for 2025-12-31 was $15.63B. Net income was $1.19B. Revenue was down 3.1% from 2024-12-31 to 2025-12-31. PFG currently screens at market cap $23.81B and trailing P/E 15.8.
PCSA currently screens at market cap $5.9M. PFG currently screens at market cap $23.81B and trailing P/E 15.8.
Not investment advice. Open the PCSA and PFG stock pages for the full models.
Not investment advice.